Endologix Inc. to Present at the 31st Annual J.P. Morgan Healthcare Conference

Published: Jan 04, 2013

IRVINE, Calif., Jan. 3, 2013 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, President and Chief Executive Officer, is scheduled to present at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

Back to news